Instil Bio, Inc. expected to post a loss of 43 cents a share - Earnings Preview
Instil Bio, Inc. <TIL.OQ> expected to post a loss of 43 cents a share - Earnings Preview
Instil Bio, Inc. TIL.OQ TIL.O is expected to show no change in quarterly revenue when it reports results on August 11 (estimated) for the period ending June 30 2026
LSEG's mean analyst estimate for Instil Bio, Inc. is for a loss of 43 cents per share.
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 2 "strong buy" or "buy," 1 "hold" and no "sell" or "strong sell."
The mean earnings estimate of analysts was unchanged in the last three months.
Wall Street's median 12-month price target for Instil Bio, Inc. is $7.00, about 3.8% below its last closing price of $7.28
This summary was machine generated August 7 at 17:39 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
Recent news on Instil Bio
See all newsInstil Bio, Inc. reports results for the quarter ended June 30 - Earnings Summary
Instil Bio Q2 net loss narrows on lower R&D spending, restructuring charges
Brief: Instil Bio Q2 Basic EPS USD -0.63
Instil Bio, Inc. expected to post a loss of 43 cents a share - Earnings Preview
Instil Bio Q1 net loss narrows on lower R&D expenses